Despite the progress of recent years, cancer remains a major cause of morbidity and mortality. The search for new diagnostic tools, medical devices or anticancer drugs is therefore very active. It is estimated that more than 900 new molecules are currently being developed around the world. Academic researchers wishing to continue their work to the proof of concept and to industrial and clinical transfer face new and specific challenges to development. Thus, MATWIN and Cancer Campus offer to the project leaders of an innovation in cancerology enrolling in this approach a one-day training “awareness” allowing them to identify the main challenges, constraints and key factors of success. development of an innovation in oncology (therapy, diagnosis or medical device) from research to early clinical practice through different themes (framework and preclinical proof of concept, development plan, project management, funding sources, fundraising , patent strategy, regulatory framework, etc.), all based on concrete examples.